Synergistic mixtures of interferons and tumor necrosis factor

Details Synergistic mixtures of interferons and tumor necrosis factor Synergistic mixtures of interferons and tumor necrosis factor

1985-06-20

1988-12-13

Rosen, Sam

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 12, 424 95, A61K 3702

Patent

active

047911018

ABSTRACT:
Ternary compositions of an interferon of the alpha and/or beta type with an interferon of the gamma type and tumor necrosis factor having a surprising and unexpected synergistic anti-proliferative effect on neoplastic cells when compared to the activity of the individual components of this invention, said compositions being useful in the treatment of neoplasia in animals including humans.

REFERENCES:
Kita et al-Chem. Abst., vol. 93 (1980), p. 93379p.
Mitsuhashi et al-Chem. Abst., vol. 98 (1983), p. 204393p.
Umeda et al-Chem. Abst., vol. 99 (1983), p. 153,665q.
Williams et al., The Journal of Immunology: 130, No. 2 (1983), pp. 518-520.
Lee et al., The Journal of Immunology: 138, No. 3 (1983), pp. 1083-1086.
Rubin et al., Proc. Natl. Acad. Sci., USA, 82:6637-6641 (Oct. 1985).
Williamson et al, "Human Tumor Necrosis Factor Produced by Human B-Cell Lines: Synergistic Cytotoxic Interaction with Human Interferon," Proc. Natl. Acad. Sci., USA, 80: 5397-5401 (1983).
Czarniecki et al, "Synergistic Antiviral and Antiproliferative Activities of Escherichia Coli-Derived Human Alpha, Beta, and Gamma Interferons," J. Virol., 49(2): 490-496 (1984).
Scorticatti et al, "Systemic Ifn-Alpha Treatment of Multiple Bladder Papilloma Grade I or II Patients: Pilot Study," J. Interferon Res., 2(3): 339-343 (1982).
Taylor-Papdimitriou et al, "Effects of HuIFN-x2 and HuIFN-x (Namalwa) on Breast Cancer Cells Grown in Culture and as Xenografts in the Nude Mouse," J. Interferon Res., 2(4): 479-491 (1982).
Quesada et al, "Clinical and Immunological Study of Beta Interferon by Intramuscular Route in Patients with Metastatic Breast Cancer," J. Interferon Res., 2(4): 593-599 (1982).
Paraf et al, "Differential Cytostatic Effect of Interferon on Murine BALB/c B- and T-Cell Tumors," J. Interferon Res., 3(2): 253-260 (1983).
Balkwill et al, "An Animal Model System for Investigating the Anti Tumor Effects of Human Interferon," J. Interferon Res., 3(3): 319-326 (1983).
Matheson et al, "Effect of Fibroblast-Derived Interferon Administration on Immune Responsiveness in a Patient with Nasopharyngeal Carcinoma," J. Interferon Res., 3(4): 437-441 (1983).
Gresser et al, "Inhibitory Effect of Mouse Interferon on the Growth of an Embryonal Carcinoma in Mice," J. Interferon Res., 4(3):375-381 (1984).
Hokland et al, "Effect of Recombinant Alpha Interferon on NK and ADCC Function in Lung Cancer Patients: Results from a Phase II Trial," J. Interferon Res., 4:561-569 (1984).
Carswell et al, "An Endotoxin-Induced Serum Factor That Causes Necrosis of Tumors," Proc. Nat. Acad. Sci., USA, 72(g): 3666-3670 (1975).
Helson et al, "Effects of Murine Tumor Necrosis Factor on Heterotransplanted Human Tumors," Expl. Cell Biol., 47: (1979).
Kull and Cuatrecasas, "Preliminary Characterization of the Tumor Cell Cytotoxin in Tumor Necrosis Serum", J. Immunol., 126(4):1279-1283 (1981).
Haranaka et al, "Antitumor Activity of Murine Tumor Necrosis Factor (TNF) Against Transplanted Murine Tumors and Heterotransplanted Human Tumors in Nude Mice," Int. J. Cancer, 34:263-267 (1984).
Hakla and Rustum, "The Potential Value of In Vitro Screening," Meth. Cancer Res., XVI:247-287 (1979).
National Cancer Institute Monograph No. 55 (NIH Publication No. 80-1933), "Experimental Evaluation of Anti-Tumor Drugs in the USA and USSR and Clinical Correlations" (1980).
Cowan and Von Hoff, "The Human Tumor Cloning Assay: An In Vitro Assay for Anti-Tumor Activity in Solid Tumors," in, Cancer Chemotherapy I, F. M. Muggia, ed., pp. 103-121, Table 3 at p. 113 (1983).
Tanneberger et al, "Pretherapeutic In Vitro Prediction of Human Tumor Drug Response," in Cancer Chemotherapy and Selective Drug Development, K. R. Harrap et al., p. 517 (1984).
Salmon, "Pre-Clinical and Clinical Applications of Chemosensitivity Testing with a Human Tumor Colony Assay," in Human Tumor Cloning, S. Salmon and J. Trent, Eds., pp. 499-508 (1984).
Venditti, "The National Cancer Institute Antitumor Drug Discovery Program, Current and Future Perspectives: A Commentary," Cancer Treatment Reps., 67(9): 767-772, at 768 (1983).
Gray et al, Nature, 312: 721-724 (1984), "Cloning and Expression of cDNA for Human Lymphotoxin, A Lymphokine with Tumor Necrosis Activity".
Pennica et al, Nature, 312:724-729 (1984), "Human Tumor Necrosis Factor: Precursor Structure, Expression and Homology to Lymphotoxin".
Imanishi et al, "Production and Characterization of Human Tumor-Degenerating Factor (TDF)", Chem. Abstr., 100: 49841x (1984).

Affiliated with

Also associated with

Rating

Synergistic mixtures of interferons and tumor necrosis factor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synergistic mixtures of interferons and tumor necrosis factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synergistic mixtures of interferons and tumor necrosis factor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2196262